Showing results (231-240 of 269) with videos related to
Sort By:
Pageof 27
Cancer Treatment Reports|November 1, 1979
Pharmacokinetics of tallysomycin and bleomycin in the beagle dogJ E Strong, J E Schurig, B F Issell, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Pharmacokinetics of carminomycin in dogs and humans. Preliminary reportS D Reich, S E Fandrich, T T Finkelstein, et al.Journal of Bacteriology|August 1, 1986
Escherichia coli iron enterobactin uptake monitored by Mössbauer spectroscopyB F Matzanke, D J Ecker, T S Yang, et al.Nucleic Acids Research|August 28, 2001
Prediction of rho-independent transcriptional terminators in Escherichia coliE A Lesnik, R Sampath, H B Levene, et al.Science (New York, N.Y.)|March 24, 1989
A multiubiquitin chain is confined to specific lysine in a targeted short-lived proteinV Chau, J W Tobias, A Bachmair, et al.Molecular Pharmacology|August 1, 1987
Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be relatedR G Shorr, M D Minnich, A Varrichio, et al.Nucleic Acids Research|June 25, 1991
Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR elementT Vickers, B F Baker, P D Cook, et al.Nucleic Acids Research|August 11, 1993
Tritium labeling of antisense oligonucleotides by exchange with tritiated waterM J Graham, S M Freier, R M Crooke, et al.AIDS Research and Human Retroviruses|November 1, 1994
Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320)R W Buckheit, J L Roberson, C Lackman-Smith, et al.The Journal of Biological Chemistry|October 5, 1992
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotidesB P Monia, J F Johnston, D J Ecker, et al.Pageof 27